BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32061916)

  • 1. Comparison of immune responses in guinea pigs by intranasal delivery with different nanoparticles-loaded FMDV DNA vaccine.
    Zheng H; Pan L; Lv J; Zhang Z; Wang Y; Hu W; Liu X; Zhou P; Wang Y; Zhang Y
    Microb Pathog; 2020 Feb; 142():104061. PubMed ID: 32061916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.
    Wang G; Pan L; Zhang Y; Wang Y; Zhang Z; Lü J; Zhou P; Fang Y; Jiang S
    PLoS One; 2011; 6(11):e27605. PubMed ID: 22110686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.
    Zhao K; Zhang Y; Zhang X; Shi C; Wang X; Wang X; Jin Z; Cui S
    Int J Nanomedicine; 2014; 9():4609-19. PubMed ID: 25356070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double synergic chitosan-coated poly (lactic-co-glycolic) acid nanospheres loaded with nucleic acids as an intranasally administered vaccine delivery system to control the infection of foot-and-mouth disease virus.
    Li X; Zhang ZW; Zhang FD; Li JH; Lv JL; Zhang LP; Zhai KG; Wang YL; Guo HC; Liu XS; Pan L
    Antiviral Res; 2024 Jun; 226():105900. PubMed ID: 38705200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens.
    Alkie TN; Yitbarek A; Taha-Abdelaziz K; Astill J; Sharif S
    PLoS One; 2018; 13(11):e0206324. PubMed ID: 30383798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
    Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants.
    Yang Y; Teng Z; Lu Y; Luo X; Mu S; Ru J; Zhao X; Guo H; Ran X; Wen X; Sun S
    Res Vet Sci; 2021 May; 136():89-96. PubMed ID: 33592449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicistronic DNA vaccine macromolecule complexed with poly lactic-co-glycolic acid-chitosan nanoparticles enhanced the mucosal immunity of Labeo rohita against Edwardsiella tarda infection.
    Leya T; Ahmad I; Sharma R; Tripathi G; Kurcheti PP; Rajendran KV; Bedekar MK
    Int J Biol Macromol; 2020 Aug; 156():928-937. PubMed ID: 32289420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Responses to Orally Administered Recombinant
    Zhang F; Zhang Z; Li X; Li J; Lv J; Ma Z; Pan L
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles.
    Kabiri M; Sankian M; Sadri K; Tafaghodi M
    Eur J Pharm Biopharm; 2018 Dec; 133():321-330. PubMed ID: 30408519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs.
    Figueiredo DB; Kaneko K; Rodrigues TDC; MacLoughlin R; Miyaji EN; Saleem I; Gonçalves VM
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced immune response of DNA vaccine (VP1-pCDNA) adsorbed on cationic PLG for foot and mouth disease in guinea pigs.
    Choudary S; Ravikumar P; Ashok Kumar C; Suryanarayana VV; Reddy GR
    Virus Genes; 2008 Aug; 37(1):81-7. PubMed ID: 18516668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Em14-3-3 delivered by PLGA and chitosan nanoparticles conferred improved protection in chicken against Eimeria maxima.
    Haseeb M; Huang J; Lakho SA; Yang Z; Hasan MW; Ehsan M; Aleem MT; Memon MA; Ali H; Song X; Yan R; Xu L; Li X
    Parasitol Res; 2022 Feb; 121(2):675-689. PubMed ID: 34984543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
    Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
    Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel formulation of Mtb72F DNA vaccine for immunization against tuberculosis.
    Dalirfardouei R; Tafaghodi M; Meshkat Z; Najafi A; Gholoobi A; Nabavinia MS; Sajedifar S; Meshkat M; Badiee A; Ramezani M; Varasteh AR; Naderinasab M
    Iran J Basic Med Sci; 2020 Jun; 23(6):826-832. PubMed ID: 32695300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics.
    Tajdini F; Amini MA; Mokarram AR; Taghizadeh M; Azimi SM
    Pharm Dev Technol; 2014 May; 19(3):333-41. PubMed ID: 23590209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.
    Terhuja M; Saravanan P; Tamilselvan RP
    Biologicals; 2015 Nov; 43(6):437-43. PubMed ID: 26493006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles.
    Zhao K; Li W; Huang T; Luo X; Chen G; Zhang Y; Guo C; Dai C; Jin Z; Zhao Y; Cui H; Wang Y
    PLoS One; 2013; 8(12):e82648. PubMed ID: 24386106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.